부산대학교 도서관

Addeo A; Oncology Department, University Hospital Geneva, Switzerland. Electronic address: alfredo.addeo@hug.ch.; Früh M; Department of Medical Oncology Cantonal Hospital of St Gallen, St Gallen, Switzerland; Department of Medical Oncology University of Bern, Bern, Switzerland.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Soo, RA; Popat, S; Dellaporta, T; De Langen, AJ; Nadal, E; Gomez, PI; Frueh, M; Pérol, M; Metro, G; Gonzalez, MAS; Salamero, MC; Cerciello, FWF; Addeo, A; Roschitzki-Vose, H; Ruepp, B; Gasca, A; Dafni, U; Peters, S; Stahel, RA

Journal of Thoracic Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)

Mohapatra S; General Internal Medicine Doctorate Programme, University of Hertfordshire, Hatfield, UK; The Misdiagnosis Association and Research Institute, Beverly Hills, USA.; Tiwari A; Department of Oncology, Princess Alexandra Hospital NHS Trust, Harlow, UK; Barts Cancer Institute, Cancer Research UK City of London Centre, Queen Mary University of London, London, UK; United Kingdom and Ireland Global Cancer Network, Manchester, UK.; Kandala A; University College London Medical School, London, UK.; Winayak R; United Kingdom and Ireland Global Cancer Network, Manchester, UK; Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Foundation Trust, Maidstone, UK.; Ghose A; Barts Cancer Institute, Cancer Research UK City of London Centre, Queen Mary University of London, London, UK; United Kingdom and Ireland Global Cancer Network, Manchester, UK; Barts Cancer Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK; Department of Research and Innovation, Medway NHS Foundation Trust, Gillingham, UK; Prevention, Early Detection and Screening Network, European Cancer Organisation, Brussels, Belgium. Electronic address: aruni.ghose1@gmail.com.; Das R; Faculty of Medicine and Health Sciences, School of Medicine, University of Nottingham, Nottingham, UK.; Hasanova M; Division of Biosciences, University College London, London, UK.; Gunani M; Department of Medicine, Allegheny Health Network, Pittsburgh, USA.; Jaswal G; Onco-Life Cancer Centre, Satara, India.; Mitra S; Fortis Cancer Institute, Fortis Memorial Research Institute, Gurugram, India.; Noronha V; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.; Jain A; Apollo Cancer Centre, Indraprastha Apollo Hospital, New Delhi, India; Deanesly Centre for Cancer Services, New Cross Hospital, The Royal Wolverhampton NHS Trust, Wolverhampton, UK.; Merletti F; Department of Medical Sciences, University of Turin, Turin, Italy.; Passaro A; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Milan, Italy.; Cortellini A; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy; Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London, UK.; Addeo A; Oncology Service, Geneva University Hospital, Geneva, Switzerland.; Banna GL; Department of Medical Oncology, Portsmouth Hospitals University NHS Trust, Portsmouth, UK; Faculty of Science and Health, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK.; Boussios S; Department of Research and Innovation, Medway NHS Foundation Trust, Gillingham, UK; Department of Medical Oncology, Ioannina University Hospital, Ioannina, Greece; Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece; Kent and Medway Medical School, University of Kent, Canterbury, UK; Faculty of Medicine, Health and Social Care, Canterbury Christ Church University, Canterbury, UK; Faculty of Life Sciences and Medicine, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK; AELIA Organization, Thessaloniki, Greece.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Frehner L; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: Lorenz.frehner@insel.ch.; Schär S; Swiss Group for Clinical Cancer Research (SAKK) Competence Center, Bern, Switzerland.; Hayoz S; Swiss Group for Clinical Cancer Research (SAKK) Competence Center, Bern, Switzerland.; Guckenberger M; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Finazzi T; Department of Radiation Oncology, Cantonal Hospital Baden, Baden, Switzerland.; Mark M; Division of Oncology/Hematology, Cantonal Hospital Graubuenden, Chur, Switzerland; Università della Svizzera italiana, Faculty of Biomedical Sciences, Lugano, Switzerland.; Addeo A; Department of Oncology, University Hospital Geneva, Geneva, Switzerland.; Mauti LA; Department of Medical Oncology, Kantonsspital Winterthur, Winterthur, Switzerland.; Betticher D; Clinic of Oncology, Cantonal Hospital Fribourg, Fribourg, Switzerland; Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.; Stupp R; Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA; Department of Medical Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland.; Curioni-Fontecedro A; Clinic of Oncology, Cantonal Hospital Fribourg, Fribourg, Switzerland; Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.; Peters S; Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.; Früh M; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Department of Medical Oncology and Hematology, HOCH Health Ostschweiz, Kantonsspital, St. Gallen, Switzerland.; Rothschild SI; Center of Oncology/Hematology and Comprehensive Cancer Center, Cantonal Hospital Baden, Baden, Switzerland.; Pless M; Swiss Group for Clinical Cancer Research (SAKK) Competence Center, Bern, Switzerland.; König D; Department of Medical Oncology, University Hospital Basel, Basel, Switzerland.; Opitz I; Department of Thoracic Surgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Ris HB; Clinics for Thoracic Surgery, Hôpital du Valais, Sion, Switzerland.; Özdemir BC; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Schmid S; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Zheng MM; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, P. R. China.; Xia Y; Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, P. R. China.; Pan K; Department of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, USA.; Sun F; Division of Oncology, Department of Medicine, Stanford University, Stanford, USA.; Tan AC; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Dong XR; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Tu HY; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, P. R. China.; Tang LB; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, P. R. China.; Li YS; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, P. R. China.; Yin K; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, P. R. China.; Borgeaud M; Department of Oncology, University Hospital Geneva, Geneva, Switzerland.; Singhal S; Division of Hematology/Oncology, UC Davis Comprehensive Cancer Center, Sacramento, USA.; Zhu E; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.; Zhang J; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.; Nilsson M; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.; Wu J; Department of Imaging Physics, University of Texas MD Anderson Cancer Center, Houston, USA.; Gibbons DL; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.; Wakelee H; Division of Oncology, Department of Medicine, Stanford University, Stanford, USA.; Neal JW; Division of Oncology, Department of Medicine, Stanford University, Stanford, USA.; Lee J; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, USA.; Vaporciyan AA; Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, USA.; Ringsurongkawong W; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.; Tran HT; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.; Zhang RZ; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, P. R. China.; Zhang T; Department of Radiation Oncology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, P. R. China.; Zhou Q; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, P. R. China; Guangdong Provincial Key Laboratory of Translation Medicine in Lung Cancer, Guangzhou, P. R. China.; Zhong WZ; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, P. R. China; Guangdong Provincial Key Laboratory of Translation Medicine in Lung Cancer, Guangzhou, P. R. China.; Li W; Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, P. R. China.; Zhang YC; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, P. R. China.; Riess JW; Division of Hematology/Oncology, UC Davis Comprehensive Cancer Center, Sacramento, USA.; Addeo A; Department of Oncology, University Hospital Geneva, Geneva, Switzerland.; Heymach JV; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.; Myall N; Division of Oncology, Department of Medicine, Stanford University, Stanford, USA.; Tan D; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, P. R. China; Guangdong Provincial Key Laboratory of Translation Medicine in Lung Cancer, Guangzhou, P. R. China. Electronic address: syylwu@live.cn.; Le X; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: xle1@mdanderson.org.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Howard HR; Cancer Institute, University College London, London, UK.; Hasanova M; Division of Biosciences, University College London, London, UK; OncoFlow™, London, UK.; Tiwari A; Cancer Services, Princess Alexandra Hospital NHS Trust, Harlow, UK; Barts Cancer Institute, Queen Mary University of London, London, UK.; Ghose A; OncoFlow™, London, UK; Barts Cancer Institute, Queen Mary University of London, London, UK; Barts Cancer Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK; Department of Research and Innovation, Medway NHS Foundation Trust, Gillingham, UK; Health Systems and Treatment Optimisation Network, European Cancer Organisation, Brussels, Belgium. Electronic address: aruni.ghose1@gmail.com.; Winayak R; Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust, Maidstone, UK.; Nahar T; School of Medicine Dentistry and Biomedical Sciences, Queen's University, Belfast, UK.; Chauhan V; Barts Cancer Institute, Queen Mary University of London, London, UK; Department of General Internal Medicine, Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, UK.; Arun S; Centre for Cancer Screening, Prevention and Early Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.; Palmer K; Department of Clinical Oncology, University College London Hospitals NHS Foundation Trust, London, UK.; Houston A; Barts Life Sciences, Barts Health NHS Trust, London, UK; Digital Environmental Research Institute, Queen Mary University of London, London, UK.; Kumar NS; College of Life Sciences, University of Leicester, Leicester, UK; National Medical Research Association, London, UK.; Lalwani S; Barts Cancer Institute, Queen Mary University of London, London, UK; Barts Cancer Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.; Januszewski A; Barts Cancer Institute, Queen Mary University of London, London, UK; Barts Cancer Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.; Conibear J; Barts Cancer Institute, Queen Mary University of London, London, UK; Barts Cancer Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.; Jain A; Apollo Cancer Centre, Indraprastha Apollo Hospital, New Delhi, India; Deanesly Centre Cancer Services, New Cross Hospital, Royal Wolverhampton NHS Trust, Wolverhampton, UK.; Cortellini A; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy; Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London, UK.; Passaro A; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Milan, Italy.; Addeo A; Oncology Service, Geneva University Hospital, Geneva, Switzerland.; Noronha V; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.; Banna GL; Department of Medical Oncology, Portsmouth Hospitals University NHS Trust, Portsmouth, UK; Faculty of Science and Health, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK.; Boussios S; Department of Research and Innovation, Medway NHS Foundation Trust, Gillingham, UK; Department of Medical Oncology, Ioannina University Hospital, Ioannina, UK; Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, UK; AELIA Organization, Thessaloniki, Greece; Kent and Medway Medical School, University of Kent, Canterbury, UK; Faculty of Medicine, Health and Social Care, Canterbury Christ Church University, Canterbury, UK; Faculty of Life Sciences and Medicine, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Soo RA; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.; Vervita K; ETOP Statistical Office, FSF-H - Frontier Science Foundation Hellas, Athens, Greece.; Früh M; Klinik für Medizinische Onkologie und Hämatologie, Kantonsspital St. Gallen, St. Gallen, Switzerland; Department of Medical Oncology, University of Bern, Bern, Switzerland.; Cho BC; Medical Oncology Department, Yonsei University, Seoul, Republic of Korea.; Majem M; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Spanish Lung Cancer Group (GECP), Barcelona, Spain.; Rodriguez Abreu D; Spanish Lung Cancer Group (GECP), Barcelona, Spain; Medical Oncology Department, Hospital Universitario Insular de Gran Canaria - Complejo Hospitalario Materno-Insular, Las Palmas De Gran Canaria, Spain.; Ribi K; Coordinating Center, ETOP IBCSG Partners Foundation, Bern, Switzerland.; Callejo A; Spanish Lung Cancer Group (GECP), Barcelona, Spain; Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Moran T; Spanish Lung Cancer Group (GECP), Barcelona, Spain; Medical Oncology Dept, ICO - Institut Català d'Oncologia Badalona (Hospital Universitario Germans Trias i Pujol), Badalona, Spain.; Domine Gomez M; Spanish Lung Cancer Group (GECP), Barcelona, Spain; Oncology Dept., Hospital Universitario Fundacion Jimenez Diaz, IIS-FJD, Madrid, Spain.; Provencio M; Spanish Lung Cancer Group (GECP), Barcelona, Spain; Universidad Autónoma de Madrid, University Hospital Puerta de Hierro Majadahonda, Majadahonda, Spain.; Addeo A; Oncology Dept., HUG - Hopitaux Universitaires de Geneve, Geneva, Switzerland.; Han JY; Center for Lung Cancer, National Cancer Center, Goyang, Republic of Korea.; Ortega Granados AL; Spanish Lung Cancer Group (GECP), Barcelona, Spain; Medical Oncology Department, Hospital Universitario de Jaén, Jaén, Spain.; Reck M; Airway Research Center North (ARCN), German Center for Lung Research (DZL), LungenClinic, Grosshansdorf, Germany.; Blasco A; Spanish Lung Cancer Group (GECP), Barcelona, Spain; Hospital General de Valencia, Spain.; Garcia Campelo R; Spanish Lung Cancer Group (GECP), Barcelona, Spain; Hospital Teresa Herrera, La Coruña, Spain.; Sala González MA; Spanish Lung Cancer Group (GECP), Barcelona, Spain; Medical Oncology Department, Hospital Universitario Basurto, Bilbao, Spain.; Britschgi C; Medical Oncology and Haematology, Universitätsspital Zürich (USZ), Zürich, Switzerland.; Roschitzki-Voser H; Coordinating Center, ETOP IBCSG Partners Foundation, Bern, Switzerland.; Ruepp B; Coordinating Center, ETOP IBCSG Partners Foundation, Bern, Switzerland.; Gasca-Ruchti A; Coordinating Center, ETOP IBCSG Partners Foundation, Bern, Switzerland.; Haberecker M; Department of Pathology and Molecular Pathology, USZ - University Hospital Zurich, Zurich, Switzerland.; Dafni U; Department of Medical Oncology, University of Bern, Bern, Switzerland; National and Kapodistrian University of Athens, Athens, Greece.; Peters S; Oncology Dept., CHUV - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Stahel RA; Coordinating Center, ETOP IBCSG Partners Foundation, Bern, Switzerland. Electronic address: rolf.stahel@etop.ibcsg.org.

Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

Brooks, H; Li, L; Addeo, A; Stevens, M; Comins, C; Oltean, S

Front Oncol
Frontiers in Oncology, Vol 13 (2023)

Decoster L; Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Department of Medical Oncology, Translational Oncology Research Center (TORC), Team Laboratory for Medical and Molecular Oncology (LMMO), Laarbeeklaan 101 1090 Brussels, Belgium. Electronic address: lore.decoster@uzbrussel.be.; Camidge DR; Division of Medical Oncology, University of Colorado, Aurora, CO 80220, USA.; Fletcher JA; Division of Cancer Services, Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba, Queensland 4102, Australia; Centre for Health Services Research, Faculty of Medicine, The University of Queensland, 199 Ipswich Road, Woolloongabba, Queensland 4102, Australia.; Addeo A; Oncology Department, University Hospital Geneva 1205 Geneva Switzerland.; Greystoke A; Institute of Clinical and Translational Medicine, NU Cancer, Newcastle University, Newcastle Upon Tyne NE7 7DN, UK.; Kantilal K; University Hospitals Sussex NHS Foundation Trust, Royal Sussex County Hospital, Pharmacy Department, Brighton BN2 5BE, UK.; Game LB; Department of Pneumology & Thoracic Oncology, CHU Toulouse-Hôpital Larrey, Toulouse, France.; Kanesvaran R; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Gomes F; Medical Oncology Department, The Christie NHS Foundation Trust, M20 4BX Manchester, UK.

Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

Prasad, V; Addeo, A

Annals of Oncology, vol 31, iss 9

König, D; Schär, S; Vuong, Diem; Guckenberger, Matthias; Furrer, K; Opitz, I; Weder, W; Rothschild, S I; Ochsenbein, A; Zippelius, A; Addeo, A; Mark, M; Eboulet, E I; Hayoz, S; Thierstein, S; Betticher, D C; Ris, H-B; Stupp, R; Curioni-Fontecedro, A; Peters, S; Pless, M; Früh, M

ESMO open, vol. 7, no. 3, pp. 100494
König, D; Schär, S; Vuong, D; Guckenberger, M; Furrer, K; Opitz, I; Weder, W; Rothschild, S I; Ochsenbein, A; Zippelius, A; Addeo, A; Mark, M; Eboulet, E I; Hayoz, S; Thierstein, S; Betticher, D C; Ris, H-B; Stupp, R; Curioni-Fontecedro, A; Peters, S; ... (2022). Corrigendum to 'Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials': [ESMO Open Volume 7, Issue 2, (2022), 100455]. ESMO open, 7(3), p. 100494. Elsevier 10.1016/j.esmoop.2022.100494

Metro G; Medical Oncology, Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Via Dottori, 1, 06156, Perugia, Italy. giulio.metro@yahoo.com.; Gili A; Public Health Section, Department of Experimental Medicine, University of Perugia, Perugia, Italy.; Signorelli D; Medical Oncology Department, National Cancer Institute of Milano, Milan, Italy.; De Toma A; Medical Oncology Department, National Cancer Institute of Milano, Milan, Italy.; Garaffa M; Medical Oncology, Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Via Dottori, 1, 06156, Perugia, Italy.; Galetta D; Thoracic Oncology Unit, IRCCS 'Giovanni Paolo II' Cancer Institute, Bari, Italy.; Economopoulou P; Oncology Department, Attikon University Hospital, Athens, Greece.; Friedlaender A; Department of Oncology, Geneva University Hospital, Geneva, Switzerland.; Jimenez B; Medical Oncology, 'HM Sanchinarro' University Hospital, Madrid, Spain.; Collazo-Lorduy A; Medical Oncology, 'HM Sanchinarro' University Hospital, Madrid, Spain.; Addeo A; Department of Oncology, Geneva University Hospital, Geneva, Switzerland.; Chiarini P; Division of Neuroradiology, Santa Maria della Misericordia Hospital, Perugia, Italy.; Costa C; Department of Medicine, Neurology Clinic, University Hospital of Perugia, Perugia, Italy.; Mountzios G; Second Department of Medical Oncology, Henry Dunant Hospital Center, Athens, Greece.; Roila F; Medical Oncology, Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy.

Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

Schuler A; Cantonal Hospital St. Gallen, Department of Medical Oncology and Haematology, Switzerland. Electronic address: alexandra.schuler@kssg.ch.; Huser J; Cantonal Hospital St. Gallen, Department of Medical Oncology and Haematology, Switzerland.; Schmid S; Cantonal Hospital St. Gallen, Department of Medical Oncology and Haematology, Switzerland; Inselspital, University Hospital Bern, Department of Medical Oncology, Switzerland.; Schär S; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung (SAKK) , Switzerland.; Scherz A; Inselspital, University Hospital Bern, Department of Medical Oncology, Switzerland.; Gautschi O; Cantonal Hospital Luzern, Department of Medical Oncology, Switzerland.; Mauti L; Cantonal Hospital Winterthur, Department of Medical Oncology and Haematology, Switzerland.; von Briel T; Clinic Hirslanden Zurich, Switzerland.; Waibel C; Cantonal Hospital Baden, Department of Medical Oncology and Haematology, Switzerland.; Wannesson L; Istituto Oncologico d. Svizzera Italiana, Switzerland.; Pankovics J; Istituto Oncologico d. Svizzera Italiana, Switzerland.; Mark MT; Cantonal Hospital Graubünden, Department of Medical Oncology and Haematology, Switzerland.; Rothschild SI; University Hospital Basel, Department of Medical Oncology, Switzerland.; Addeo A; University Hospital Geneva, Department of Medical Oncology, Switzerland.; Janthur WD; Cantonal Hospital Aarau, Department of Medical Oncology, Switzerland.; Siano M; Seeland Cancer Center, Bern-Biel, Switzerland.; Boos L; Comprehensive Cancer Center Zurich, Department of Medical Oncology and Haematology, Switzerland.; Britschgi C; Comprehensive Cancer Center Zurich, Department of Medical Oncology and Haematology, Switzerland.; Früh M; Cantonal Hospital St. Gallen, Department of Medical Oncology and Haematology, Switzerland; Inselspital, University Hospital Bern, Department of Medical Oncology, Switzerland.

Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

Bini, R; Addeo, A; Maganuco, L; Fontana, D; Viora, T; Leli, R

Annals of the Royal College of Surgeons of England. Jul 01, 2014 96(5):e31-e33

König, D; Savic Prince, S; Hayoz, S; Zens, P; Berezowska, S; Jochum, W; Stauffer, E; Braunersreuther, V; Trachsel, B; Thierstein, S; Mark, M; Schmid, S; Curioni-Fontecedro, A; Addeo, A; Opitz, I; Guckenberger, M; Früh, M; Betticher, D C; Ris, H-B; Stupp, R; Rothschild, S I; Bubendorf, L; Pless, M

ESMO Open
ESMO open, vol. 8, no. 4, pp. 101595
König, D; Savic Prince, S; Hayoz, S; Zens, P; Berezowska, S; Jochum, W; Stauffer, E; Braunersreuther, V; Trachsel, B; Thierstein, S; Mark, M; Schmid, S; Curioni-Fontecedro, A; Addeo, A; Opitz, I; Guckenberger, M; Früh, M; Betticher, D C; Ris, H-B; Stupp, R; ... (2023). Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14. ESMO open, 8(4), p. 101595. BMJ 10.1016/j.esmoop.2023.101595

Banna GL; Division of Medical Oncology, Cannizzaro Hospital, Catania, Italy.; Deparment of Oncology, United Lincolnshire NHS Hospital Trust, Lincoln, UK.; Di Quattro R; Department of Clinical and Experimental Medicine, University of Catania, Cannizzaro Hospital, Catania, Italy.; Malatino L; Department of Clinical and Experimental Medicine, University of Catania, Cannizzaro Hospital, Catania, Italy.; Fornarini G; Medical Oncology Unit, Ospedale Policlinico San Martino, Genoa, Italy.; Addeo A; Oncology Department, Geneva University Hospital, Geneva, Switzerland.; Maruzzo M; Medical Oncology Unit 1, Istituto Oncologico Veneto IOV IRCCS, Padua, Italy.; Urzia V; Department of Clinical and Experimental Medicine, University of Catania, Cannizzaro Hospital, Catania, Italy.; Rundo F; STMicroelectronics ADG Central R&D, Catania, Italy.; Lipari H; Division of Medical Oncology, Cannizzaro Hospital, Catania, Italy.; De Giorgi U; Istituto Scientifico Romagnolo per io Studio e La Cura Dei Tumori (IRST) IRCCS, Meldola, FC, Italy. ugo.degiorgi@irst.emr.it.; Basso U; Medical Oncology Unit 1, Istituto Oncologico Veneto IOV IRCCS, Padua, Italy.

Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

Camerini A; Medical Oncology, Versilia Hospital - ASL Toscana Nord-Ovest, via Aurelia 335, 55043, Lido di Camaiore, LU, Italy. andrea.camerini@uslnordovest.toscana.it.; Banna GL; Division of Medical Oncology, Cannizzaro Hospital, via Messina 829, 95126, Catania, Italy.; Cinieri S; Medical Oncology, Perrino Hospital, Strada Statale 7 per Mesagne, 72100, Brindisi, Italy.; Pezzuto A; Department of Cardio-Thoracic-Vascular Science, S. Andrea Hospital, Via di Grottarossa, 1035, 00189, Rome, Italy.; Mencoboni M; Medical Oncology, ASL 3 Genovese, Ospedale Villa Scassi, Corso Onofrio Scassi 1, 16121, Genoa, Italy.; Rosetti F; Medical Oncology, ULSS3 Serenissima, Distretto Mirano-Dolo, Via Pasteur, 30031, Dolo, VE, Italy.; Figueiredo A; Pneumology, Centro Hospitalar e Universitario de Coimbra, Avenida Doutor Bissaya Barreto S/N, Praceta De Mota Pinto, Celas-Coimbra, Portugal.; Rizzo P; Medical Oncology, Perrino Hospital, Strada Statale 7 per Mesagne, 72100, Brindisi, Italy.; Ricci A; Department of Molecular and Clinical Medicine, S. Andrea Hospital, Via di Grottarossa, 1035, 00189, Rome, Italy.; Langenhoven L; Clinical Oncology, Panorama Oncology Centre, 43 Hennie Winterbach St, Panorama, Cape Town, 7500, South Africa.; Santo A; Medical Oncology, University Hospital of Verona, Piazzale Aristide Stefani 1, 37126, Verona, Italy.; Addeo A; Oncology Department, University Hospital Geneva, Rue Gabrielle-Perret-Gentil 4, 1205, Geneva, Switzerland.; Amoroso D; Medical Oncology, Versilia Hospital - ASL Toscana Nord-Ovest, via Aurelia 335, 55043, Lido di Camaiore, LU, Italy.; Barata F; Pneumology, Centro Hospitalar e Universitario de Coimbra, Avenida Doutor Bissaya Barreto S/N, Praceta De Mota Pinto, Celas-Coimbra, Portugal.

Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

Novarino, A; Durando, R; Donadio, M; Icardi, M; Ritorto, G; Occelli, M; Buffoni, L; Addeo, A; Robecchi, A; Bertetto, O

Annals of Oncology. Jan 01, 2000 11 Suppl 2:71-71

König, D; Schär, S; Vuong, Diem; Guckenberger, Matthias; Furrer, K; Opitz, I; Weder, W; Rothschild, S I; Ochsenbein, A; Zippelius, A; Addeo, A; Mark, M; Eboulet, E I; Hayoz, S; Thierstein, S; Betticher, D C; Ris, H-B; Stupp, R; Curioni-Fontecedro, A; Peters, S; Pless, M; Früh, M

ESMO Open
ESMO open, vol. 7, no. 2, pp. 100455
König, D; Schär, S; Vuong, D; Guckenberger, M; Furrer, K; Opitz, I; Weder, W; Rothschild, S I; Ochsenbein, A; Zippelius, A; Addeo, A; Mark, M; Eboulet, E I; Hayoz, S; Thierstein, S; Betticher, D C; Ris, H-B; Stupp, R; Curioni-Fontecedro, A; Peters, S; ... (2022). Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials. ESMO open, 7(2), p. 100455. Elsevier 10.1016/j.esmoop.2022.100455

CHIAPPINO I; DESTEFANIS, Paolo Giuseppe; ADDEO A; GALETTO A; CUCCHIARALE G; MUNOZ F; ZITELLA A; FERRANDO U; FONTANA, Dario; RICARDI, Umberto; TIZZANI, Alessandro; BERTETTO O.

American Journal of Clinical Oncology. 30:234-238